TTX
TTRATHERIX FPO [TTX]
Healthcare · ASX Small Cap
$7.0600 -1.9%
Updated 3 Sep 2026 · Signals refresh every scan
Appeared in 2 consecutive scansFirst seen: 2026-03-16
Get alerts when TTX triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- Golden cross just fired — the short-term trend is overtaking the long-term, which is classically bullish
- Above-average volume (1.7x) on a red day — sellers in control
- Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
- Trading above the 200-day average — the long-term trend is on your side
- Strong cash runway (58 quarters)
- 4C filed 2026-07-21
- Very high P/S ratio (98.5x)
- Strong revenue growth (+314%)
- EPS estimates revised upward (+10pts)
- CANSLIM S: Tight float (24%)
- Sentiment is mixed — no strong consensus either way
- Strong long-term momentum — up 93% over the past year (excluding last month)
- Revenue growing at +314% — the top line is moving in the right direction
- The bigger volume days are the up days — volume-weighted momentum is positive (0.66%/day)
- RBA hiking (-3pts)
Risk Signals
- Stochastic is stretched into overbought — could need a breather
- Deeply negative margins (-241%)
- Not enough chatter to gauge sentiment — defaulting to neutral
Ask Scout AI about TTX
3 free messages/day · Unlimited with Pro
Recent Catalysts
NONE Tetratherix Ships First US Polymer, Revenue Begins
NONE Application for quotation of securities - TTX
NONE Results Presentation 2026
LOW Appendix 4E and Annual Report 2026
LOW Quarterly Activities/Appendix 4C Cash Flow Report
Recent ASX Announcements
| 2026-08-30 | Tetratherix Ships First US Polymer, Revenue Begins |
| 2026-08-24 | Application for quotation of securities - TTX |
| 2026-08-20 | Results Presentation 2026 |
| 2026-08-19 | Appendix 4E and Annual Report 2026 PRICE SENSITIVE |
| 2026-07-21 | Quarterly Activities/Appendix 4C Cash Flow Report PRICE SENSITIVE |
Key Metrics
$380.4M
Market Cap
29K
Avg Volume
1.7x
Vol Ratio
$3.09 — $8.08
52-Week Range
N/A
Short Interest
20 qtrs
Cash Runway
-31.1%
ROE
-241.4%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | pass | Float: 24% |
| L | Leader vs Laggard | pass | RS: 9 |
| I | Institutional Sponsorship | weak | Inst: 3% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
113 tickers in this sector
View all Healthcare signals →Browse all ASX tickers A–Z →Track TTX and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.
No credit card required